Lemakalim

N/A

Report date: 2022/06/06 15:48:52
NME

Base Information

Drug NameLemakalim
Drug Alias Name(+)-cromakalim克罗卡林左旋克罗卡林Levanex(3S,4R)-(-)-cromakalim +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSulfonylurea receptor agonists
TargetsSulfonylurea receptor
Therapy Area/IndicationsHypertensionMyocardial IschemiaArrhythmias, Cardiac +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeiji Seika PharmaGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHypertensionMyocardial IschemiaArrhythmias, Cardiac +[4] 

Other Information

ATC CodeN/A
Related LinksN/A